CAS: 262352-17-0 - Torcetrapib

Fórmula: C₂₆H₂₅F₉N₂O₄

InChI: InChI=1S/C26H25F9N2O4/c1-4-18-12-21(19-11-15(24(27,28)29)6-7-20(19)37(18)23(39)41-5-2)36(22(38)40-3)13-14-8-16(25(30,31)32)10-17(9-14)26(33,34)35/h6-11,18,21H,4-5,12-13H2,1-3H3/t18-,21+/m1/s1

Clave InChI: InChIKey=CMSGWTNRGKRWGS-NQIIRXRSSA-N

SMILES: O=C(OC)N(CC=1C=C(C=C(C1)C(F)(F)F)C(F)(F)F)C2C3=CC(=CC=C3N(C(=O)OCC)C(CC)C2)C(F)(F)F

Sinónimos:

• (2R,4S)-4-[(3,5-Bis-trifluoromethylbenzyl)methoxycarbonylamino]-2-ethyl-6-trifluoromethyl-3,4-dihydro-2H-quinoline-1-carboxylic acid ethyl ester
• (2R,4S)-4-[[3,5-Bis(trifluoromethyl)benzyl]methoxycarbonylamino]-2-ethyl-6-trifluoromethyl-3,4-dihydro-2H-quinoline-1-carboxylic acid ethyl ester
• 1(2H)-Quinolinecarboxylic acid, 4-[[[3,5-bis(trifluoromethyl)phenyl]methyl](methoxycarbonyl)amino]-2-ethyl-3,4-dihydro-6-(trifluoromethyl)-, ethyl ester, (2R,4S)-
• Cp 529414
• ethyl (2R,4S)-4-{[3,5-bis(trifluoromethyl)benzyl](methoxycarbonyl)amino}-2-ethyl-6-(trifluoromethyl)-3,4-dihydroquinoline-1(2H)-carboxylate
• Torcetrapib

1(2H)-Quinolinecarboxylic acid, 4-[[[3,5-bis(trifluoromethyl)phenyl]methyl](methoxycarbonyl)amino]-2-ethyl-3,4-dihydro-6-(trifluoromethyl)-, ethyl ester, (2R,4S)-

CAS: 262352-17-0

• Fórmula: C₂₆H₂₅F₉N₂O₄
• Pureza: 98%
• Forma y color: Solid
• Peso molecular: 600.4733

Torcetrapib

CAS: 262352-17-0

• Fórmula: C₂₆H₂₅F₉N₂O₄
• Peso molecular: 600.47

Torcetrapib

CAS: 262352-17-0

• Fórmula: C₂₆H₂₅F₉N₂O₄
• Forma y color: White To Off-White Solid
• Peso molecular: 600.49

Torcetrapib

CAS: 262352-17-0

Torcetrapib (CP-529414), a CETP inhibitor, curbs cholesteryl ester movement from HDL to LDL/VLDL; failed Phase …

• Fórmula: C₂₆H₂₅F₉N₂O₄
• Pureza: 98% - 99.59%
• Forma y color: Lipid
• Peso molecular: 600.47

Torcetrapib

CAS: 262352-17-0

Applications Cholesteryl ester transfer protein (CETP) inhibitor. Antilipemic; antiatherosclerotic. References Burnett, J.R., et al.: Curr. …

• Fórmula: C₂₆H₂₅F₉N₂O₄
• Forma y color: Neat
• Peso molecular: 600.47

Torcetrapib

CAS: 262352-17-0

Torcetrapib is a drug that inhibits the enzyme DPP-IV, which is responsible for the degradation …

• Pureza: Min. 95%